Aethlon Medical, Inc. (AEMD)
Total Valuation
AEMD has a market cap or net worth of $5.46 million. The enterprise value is -$4.04 million.
| Market Cap | 5.46M |
| Enterprise Value | -4.04M |
Important Dates
The next estimated earnings date is Monday, February 12, 2024, after market close.
| Earnings Date | Feb 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AEMD has 2.49 million shares outstanding. The number of shares has increased by 19.72% in one year.
| Shares Outstanding | 2.49M |
| Shares Change (YoY) | +19.72% |
| Shares Change (QoQ) | +2.15% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 3.24% |
| Float | 2.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.21 |
| PS Ratio | 9.51 |
| Forward PS | n/a |
| PB Ratio | 0.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.13, with a Debt / Equity ratio of 0.08.
| Current Ratio | 6.13 |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.40% and return on invested capital (ROIC) is -107.14%.
| Return on Equity (ROE) | -83.40% |
| Return on Assets (ROA) | -69.60% |
| Return on Capital (ROIC) | -107.14% |
| Revenue Per Employee | $38,283 |
| Profits Per Employee | -$775,555 |
| Employee Count | 15 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.12% in the last 52 weeks. The beta is 1.47, so AEMD's price volatility has been higher than the market average.
| Beta (1Y) | 1.47 |
| 52-Week Price Change | -15.12% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 2.94 |
| Relative Strength Index (RSI) | 64.61 |
| Average Volume (30 Days) | 24,374 |
Short Selling Information
The latest short interest is 81,544, so 3.27% of the outstanding shares have been sold short.
| Short Interest | 81,544 |
| Short Previous Month | 122,376 |
| Short % of Shares Out | 3.27% |
| Short % of Float | 3.34% |
| Short Ratio (days to cover) | 3.54 |
Income Statement
In the last 12 months, AEMD had revenue of $574,245 and -$11.63 million in losses. Loss per share was -$4.92.
| Revenue | 574,245 |
| Gross Profit | 574,245 |
| Operating Income | -11.91M |
| Pretax Income | -11.63M |
| Net Income | -11.63M |
| EBITDA | -11.28M |
| EBIT | -11.63M |
| Loss Per Share | -$4.92 |
Balance Sheet
The company has $10.30 million in cash and $798,451 in debt, giving a net cash position of $9.50 million or $3.81 per share.
| Cash & Cash Equivalents | 10.30M |
| Total Debt | 798,451 |
| Net Cash | 9.50M |
| Net Cash Per Share | $3.81 |
| Equity / Book Value | 10.32M |
| Book Value Per Share | 4.14 |
| Working Capital | 8.78M |
Cash Flow
In the last 12 months, operating cash flow was -$10.08 million and capital expenditures -$399,928, giving a free cash flow of -$10.48 million.
| Operating Cash Flow | -10.08M |
| Capital Expenditures | -399,928 |
| Free Cash Flow | -10.48M |
| FCF Per Share | -$4.22 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,074.23% and -2,025.85%.
| Gross Margin | 100.00% |
| Operating Margin | -2,074.23% |
| Pretax Margin | -2,025.85% |
| Profit Margin | -2,025.85% |
| EBITDA Margin | -1,963.83% |
| EBIT Margin | -2,025.85% |
| FCF Margin | -1,825.75% |
Dividends & Yields
AEMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -213.09% |
| FCF Yield | -192.04% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.72% |
| Shareholder Yield | -19.72% |
Analyst Forecast
The average price target for AEMD is $23.00, which is 950.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.00 |
| Price Target Difference | 950.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 5, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 5, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
AEMD has an Altman Z-Score of -17.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.05 |
| Piotroski F-Score | 3 |